Table 1 Baseline characteristics
| Â | Initiation of renal replacement therapy | |
|---|---|---|
(–) | (+) | |
Number of subjects | 149,325 | 295 |
Follow-up time, years, median [IQR] | 2.3 [1.2, 3.4] | 1.9 [1.0, 3.0] |
Age, years, median [IQR] | 52 [46, 59] | 51 [46, 56] |
Type of insurance, n (%) | ||
 Insured workers | 119,762 (80.2) | 274 (92.9) |
 Dependents | 29,563 (19.8) | 21 (7.1) |
Females, n (%) | 44,372 (29.7) | 34 (11.5) |
BMI, kg/m2, mean (SD) | 24.0 (4.1) | 24.9 (4.9) |
eGFR, ml/min/1.73 m2, median [IQR] | 59 [56, 74] | 15 [8, 33] |
eGFR<60 ml/min/1.73 m2, n (%) | 53,858 (36.1) | 98 (33.2) |
Proteinuria (1+ or more, dipstick), n (%) | 60,318 (40.4) | 232 (78.6) |
Diagnosis of CKD, n (%) | 44,701 (29.9) | 234 (79.3) |
Medication for diabetes, n (%) | 17,804 (11.9) | 113 (38.3) |
Medication for hypertension, n (%) | 45,669 (30.6) | 263 (89.2) |
Medication for hypercholesterolemia, n (%) | 30,428 (20.4) | 147 (49.8) |
History of cardiovascular disease, n (%) | 21,571 (14.4) | 115 (39.0) |
History of cerebrovascular disease, n (%) | 8156 (5.5) | 34 (11.5) |
Number of checkups received, median [IQR] | 2 [1, 4] | 2 [1, 3] |